Is next-generation sequencing an important tool in HPV subtype diagnosis?

Expert Review of Molecular Diagnostics

Volumn 12, Issue 7, 2012, Pages 663-665

  Wood, Henry M ^a   Bolt, Robert ^b   Hunter, Keith D ^c  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b CHARLES CLIFFORD DENTAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

clinical sequencing; HPV; next generation sequencing; subtype; viral load

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; MESSENGER RNA; PROTEIN P16;

ANUS CARCINOMA; CLINICAL DECISION MAKING; GENE SEQUENCE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 61; HUMAN PAPILLOMAVIRUS TYPE 6B; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NEXT GENERATION SEQUENCING; NONHUMAN; OROPHARYNX CARCINOMA; OUTCOME ASSESSMENT; PAPILLOMAVIRUS INFECTION; PENIS CARCINOMA; POLYMERASE CHAIN REACTION; PROGNOSIS; RELIABILITY; REVIEW; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VAGINA CARCINOMA; VIRUS GENOME; VIRUS IDENTIFICATION; VIRUS LOAD; VULVA CARCINOMA; WART VIRUS;

HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS;

EID: 84869405040     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/erm.12.67     Document Type: Review

References (20)

1. Dürst M, Gissmann L, Ikenberg H, zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc. Natl Acad. Sci. USA 80(12), 3812-3815 (1983). (Pubitemid 13063146)
2. De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int. J. Cancer 124(7), 1626-1636 (2009).
3. Backes DM, Kurman RJ, Pimenta JM, Smith JS. Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes. Control. 20(4), 449-457 (2009).
4. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol. Biomarkers Prev. 14(2), 467-475 (2005). (Pubitemid 40270113)
5. Burger RA, Monk BJ, Kurosaki T et al. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer. J. Natl Cancer Inst. 88(19), 1361-1368 (1996). (Pubitemid 26329753)
6. Kim JY, Park S, Nam BH et al. Low initial human papilloma viral load implicates worse prognosis in patients with uterine cervical cancer treated with radiotherapy. J. Clin. Oncol. 27(30), 5088-5093 (2009).
7. Gillison ML. Human papillomavirus and prognosis of oropharyngeal squamous cell carcinoma: implications for clinical research in head and neck cancers. J. Clin. Oncol. 24(36), 5623-5625 (2006). (Pubitemid 46631299)
8. Smeets SJ, Hesselink AT, Speel EJ et al. A novel algorithm for reliable detection of human papillomavirus in paraffn-embedded head and neck cancer specimen. Int. J. Cancer 121(11), 2465-2472 (2007). (Pubitemid 350022416)
9. Martró E, Valencia MJ, Tarrats A et al. Comparison between two human papillomavirus genotyping assays targeting the L1 or E6/E7 region in cervical cancer biopsies. Enferm. Infecc. Microbiol. Clin. 30(5), 225-229 (2012).
10. Im SS, Wilczynski S P, Burger RA, Monk BJ. Early stage cervical cancers containing human papillomavirus type 18 DNA have more nodal metastasis and deeper stromal invasion. Clin. Cancer Res. 9(11), 4145-4150 (2003). (Pubitemid 37204032)
11. Kónya J, Veress G, Hernádi Z, Soós G, Czeglédy J, Gergely L. Correlation of human papillomavirus 16 and 18 with prognostic factors in invasive cervical neoplasias. J. Med. Virol. 46(1), 1-6 (1995).
12. Khan MJ, Castle PE, Lorincz AT et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specifc HPV testing in clinical practice. J. Natl Cancer Inst. 97(14), 1072-1079 (2005). (Pubitemid 41417924)
13. Tran B, Dancey JE, Kamel-Reid S et al. Cancer genomics: technology, discovery, and translation. J. Clin. Oncol. 30(6), 647-660 (2012).
14. Jones SJ, Laskin J, Li YY et al. Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors. Genome Biol. 11(8), R82 (2010).
15. Morgan JE, Carr IM, Sheridan E et al. Genetic diagnosis of familial breast cancer using clonal sequencing. Hum. Mutat. 31(4), 484-491 (2010).
16. Barzon L, Militello V, Lavezzo E et al. Human papillomavirus genotyping by 454 next generation sequencing technology. J. Clin. Virol. 52(2), 93-97 (2011).
17. Duncavage EJ, Magrini V, Becker N et al. Hybrid capture and next-generation sequencing identify viral integration sites from formalin-fxed, paraffn-embedded tissue. J. Mol. Diagn. 13(3), 325-333 (2011).
18. Conway C, Chalkley R, High A et al. Next-generation sequencing for simultaneous determination of human papillomavirus load, subtype, and associated genomic copy number changes in tumors. J. Mol. Diagn. 14(2), 104-111 (2012).
19. Klussmann J P, Mooren JJ, Lehnen M et al. Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications. Clin. Cancer Res. 15(5), 1779-1786 (2009).
20. Kriesel JD, Hobbs MR, Jones BB, Milash B, Nagra RM, Fischer K F. Deep sequencing for the detection of virus-like sequences in the brains of patients with multiple sclerosis: detection of GBV-C in human brain. PloS ONE 7(3), e31886 (2012).